Rigel Pharmaceuticals recently announced the enrollment of the first patient in the dose expansion phase of its ongoing Phase 1b study of R289 in relapsed or refractory lower-risk myelodysplastic ...

Investing.com - Rigel Pharmaceuticals (NASDAQ:RIGL), which has demonstrated strong financial health with an EXCELLENT rating according to InvestingPro metrics, announced Wednesday that the first ...

Dose expansion phase will determine the recommended Phase 2 dose of R289 for patients with transfusion dependent R/R lower-risk MDS SOUTH SAN FRANCISCO, Calif., Oct. 8, 2025 /PRNewswire/ -- Rigel ...

Rigel Pharmaceuticals is a commercial-stage biotech growing revenue with three marketed drugs and a promising pipeline. RIGL's product sales grew 72% YoY in 1H FY2025, with diversification reducing ...

A noteworthy insider acquisition was disclosed on September 17, as Rojkjaer, EVP at Rigel Pharmaceuticals (NASDAQ:RIGL), reported the acquisition of stock options for 7,394 shares. What Happened: ...

A substantial acquisition of company stock options by Raymond Furey, EVP at Rigel Pharmaceuticals (NASDAQ:RIGL) was reported on September 17, based on a new SEC filing. What Happened: Revealed in a ...

President Trump gave an update on his youngest son Barron’s progress at New York University shortly before the first son started his sophomore year at a satellite campus in Washington, DC. Trump ...

This vlog takes you inside the world of bike parkour, capturing extreme tricks, creative lines, and the energy behind every ride. From urban environments to scenic spots, the vlog follows the ...

Bhad Bhabie recently launched a vlog series on YouTube, and the latest episode has offered an unfiltered look at the complicated relationship between her and the father of her child. In the second ...

In a world of niche content, it's hard to predict what could capture the internet's attention next, but two North Yorkshire farmers might have cracked the code. Church Fenton residents Martin and ...